Cerdelga OverviewEliglustat (INN, USAN; trade name Cerdelga) is a treatment for Gaucher's disease developed by Genzyme Corp that was approved by the FDA August 2014. Commonly used as the tartrate salt, the compound is believed to work by inhibition of glucosylceramide synthase. According to an article in Journal of the American Medical Association the oral substrate reduction therapy resulted in "significant improvements in spleen vol...
Read more Cerdelga Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Eliglustat
Recent Cerdelga Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Capsule: 84 Mg., 84mg
NDC Database Records for Cerdelga: (1 result)Sorted by National Drug Code
- 58468-0220 Cerdelga 84 mg Oral Capsule by Genzyme Corporation